While the majority of people who get Wuhan Flu will be asymptomatic or only have mild symptoms, those who do go full-blown-flu need treatments. Hydroxychloroquine was an early (political football) treatment that the FDA approved. They have just approved another.
Related: We have the Video of the Urgent Care Doctors Challenging Lockdowns that Big Digital Censored
“FDA’s emergency authorization of remdesivir, two days after the National Institutes of Health’s clinical trial showed promising results, is a significant step forward in battling COVID-19 and another example of the Trump Administration moving as quickly as possible to use science to save lives,” said HHS Secretary Alex Azar. “NIH, FDA, and scientists across America and around the world have worked tirelessly with patients to get us this new potential treatment for COVID-19. The seamless cooperation between government and private industry under the President’s all-of-America approach to COVID-19 is getting treatment options to patients in record time.”
We are told that remdesivir has shown some ability to speed recovery during trials by several days. Given the concern about keeping beds available in hospitals and care facilities, if we ever experience an actual surge in hospitalizations, freeing up beds a few days sooner for every patient makes mathematical sense. And any treatment that could potentially save lives is worth examining further.
While it has been approved by the FDA for emergency use, further data is needed to determine what benefits it can provide in the short and long term.
Note: Further research has revealed that this is another trojan horse for carrying money to Big Pharma
